What are the possible causes and recommended evaluation and management for frequent epistaxis confined to the left nostril?

Frequent Unilateral (Left Nostril) Epistaxis: Evaluation and Management

For recurrent bleeding confined to one nostril, you must perform or refer for nasal endoscopy to identify the bleeding source and rule out serious underlying pathology, as unilateral epistaxis raises concern for structural lesions, tumors, or foreign bodies that cannot be adequately visualized with anterior rhinoscopy alone 1.

Why Unilateral Bleeding Demands Endoscopy

Recurrent unilateral epistaxis is a red flag that distinguishes this from typical bilateral nosebleeds. The 2020 AAO-HNS guidelines specifically recommend nasal endoscopy for patients with recurrent unilateral nasal bleeding, as this presentation pattern is associated with:

• Nasal malignancies (present with unilateral obstruction in 66.7% and epistaxis in 55% of cases, often not visible on anterior rhinoscopy) 1
• Juvenile nasopharyngeal angiofibroma in adolescent males (presents with unilateral, profuse epistaxis in 60-76% of cases) 1
• Nasal foreign bodies (epistaxis is the presenting symptom in 7% of cases, with bleeding in 30% overall) 1
• Septal pathology including deviation or perforation 1

With nasal endoscopy, the bleeding site can be localized in 87-93% of cases, compared to much lower rates with anterior rhinoscopy alone 1.

Initial Assessment Steps

Before endoscopy, perform these specific evaluations:

Medication History

• Anticoagulants/antiplatelets: Ask about warfarin, DOACs, aspirin, clopidogrel, and recent dosage changes 1
• Check INR if patient takes warfarin to assess therapeutic range 1
• Intranasal medications: Nasal corticosteroids increase epistaxis risk 2.74-fold (RR range 1.88-4.00) and should be discontinued in recurrent cases 1
• Inquire about intranasal drugs of abuse 1

Blood Pressure

• Document current blood pressure, though hypertension lacks causal evidence as a primary risk factor 1
• Blood pressure management decisions should be based on bleeding severity and individual comorbidities 1

Anterior Rhinoscopy First

• Remove any blood clot by suction or gentle nose blowing to visualize the anterior cavity 1
• Look for anterior bleeding sites, septal deviation, or perforation 1
• This may identify anterior sources amenable to immediate treatment, but does not replace endoscopy for unilateral cases 1

Treatment Algorithm Based on Findings

If Anterior Bleeding Site Identified

Apply one or more of these interventions 1:

• Topical vasoconstrictors: Oxymetazoline, phenylephrine, epinephrine, or cocaine
• Nasal cautery: Silver nitrate for localized bleeding or prominent vessels
• Moisturizing/lubricating agents: After bleeding control to prevent recurrence

If Endoscopy Reveals Specific Pathology

• Structural lesions or tumors: Refer to otolaryngology for biopsy and definitive management
• Posterior bleeding sites: Can occur from septum (70%) or lateral nasal wall (24%), requiring targeted endoscopic therapy 1
• Foreign body: Remove under endoscopic visualization (particularly urgent for disk batteries, which cause tissue necrosis within 3 hours) 1

Special Consideration: Endemic Areas

In patients from rural areas or with history of drinking from stagnant water sources, consider nasal leech infestation as a rare but documented cause of persistent unilateral epistaxis 2, 3. Endoscopy allows identification and removal with vascular forceps.

Management of Anticoagulated Patients

Do not reverse anticoagulation or withhold medications unless bleeding is life-threatening 1. First-line treatments (compression, vasoconstrictors, cautery, packing) should be attempted first, as reversal agents carry significant thrombotic risks 1.

Critical Pitfalls to Avoid

• Never assume unilateral bleeding is benign without endoscopy: Delayed diagnosis of tumors or vascular malformations can result in life-threatening bleeding 1
• Don't rely solely on anterior rhinoscopy: Even when an anterior source is identified, endoscopy may still be indicated if bleeding was difficult to control or clinical signs suggest additional pathology 1
• Don't stop anticoagulation prematurely: Patients on these medications usually have serious underlying conditions requiring continued therapy 1

Follow-Up Requirements

Document 30-day outcomes for all treated patients to assess treatment effectiveness and identify recurrent bleeding 1. Routine follow-up is particularly important after invasive treatments to monitor for complications including persistent obstruction, pain, or severe crusting 1.